4.7 Review

Platelets as delivery systems for disease treatments

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 62, 期 12, 页码 1196-1203

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2010.06.007

关键词

Gene therapy; Platelet-specific promoter; Platelet; Hemostasis

资金

  1. American Heart Association [0730183N]
  2. National Hemophilia Foundation
  3. Hemophilia Association of New York
  4. National Institutes of Health [HL-102035, HL-44612]
  5. Goerlich Foundation
  6. Bayer Hemophilia Award

向作者/读者索取更多资源

Platelets are small, anucleate, discoid shaped blood cells that play a fundamental role in hemostasis. Platelets contain a large number of biologically active molecules within cytoplasmic granules that are critical to normal platelet function. Because platelets circulate in blood through out the body, release biological molecules and mediators on demand and participate in hemostasis as well as many other pathophysiologic processes, targeting expression of proteins of interest to platelets and utilizing platelets as delivery systems for disease treatment would be a logical approach. This paper reviews the genetic therapy for inherited bleeding disorders utilizing platelets as delivery system, with a particular focus on platelet-derived FVIII for hemophilia A treatment. (c) 2010 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据